Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Agriculture
Automobiles
Business
Construction/Realestate
Culture/Entertainment
Education
Energy/Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy/Government
Retail
Society
Sports
Technology
Transportation
Travel
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Agriculture
Automobiles
Business
Construction / Realestate
Culture / Entertainment
Education
Energy / Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy / Government
Retail
Society
Sports
Technology
Transportation
Travel
Health News Releases
Today December 8
September 20, 09:55
Takeda Commits Over $30 Million in Five New Global CSR Partnerships To Further Drive Health Impact in 92 Countries
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced five new partnerships to its Global Corporate Social Responsibility (CSR) Program, which contribute to strengthe
September 19, 10:10
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
PRESS RELEASE - FOR TRADE, BUSINESS AND MEDICAL MEDIA ONLY Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of est
September 17, 15:40
Biocytogen Officially Launches RenMice® Series
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice a
September 15, 13:20
SK Capital Completes Strategic Investment in Ecopol
Ecopol S.p.A. (“Ecopol” or the “Company”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today the completion of a strategic investment from affili
September 14, 17:18
Boehringer Ingelheim receives SBTi validation for CO2 reduction targets
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, said on Thursday it is well on track to achieve its 2030 emission reduction targets, and that it had received approval of tho
September 14, 16:55
Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
Ahead of discussions at the United Nations General Assembly (UNGA78), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has warned that current pandemic preparednes
September 14, 16:19
AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment
Powering AstraZeneca’s transition to net zero, the Company has agreed a 15-year partnership with Future Biogas to establish the UK’s first unsubsidised industrial-scale supply of biomethane gas, and i
September 14, 09:45
ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as
September 13, 11:20
KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb (https://www.kbibiopharma.com/suremab-efficient-antibody-development)™, an offering built on the robustnes
September 12, 16:10
Monrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity
Eczacıbaşı Monrol Nuclear Products Co. (Monrol), one of the world’s leading radiopharmaceutical producers, has decided to invest 35 million Euros to increase its production capacity for non-carrier-ad
September 12, 10:20
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its
September 12, 09:33
Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial eva
September 08, 15:45
Morinaga Milk’s Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, is pleased to announce that its proprietary probiotic strain Bifidobacterium longum subsp. longum BB536 (hereaf
September 08, 11:10
Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces an antibody evaluation, o
September 08, 10:05
Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board
Lysando, leading biotech in antimicrobial proteins, proudly announces the addition of Mr. Jorge Cortell to its esteemed Advisory Board marking a significant milestone in the company’s growth. As a ser
September 06, 13:45
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that its Board of Directors (the “Board of Directors”) unani
September 06, 11:15
Organon Bolsters Research & Development Expertise with Two Leadership Appointments
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owen
September 06, 09:11
LabGenomics USA LLC Acquires QDx Pathology in a Strategic Move to Expand its Diagnostic Lab Services and IVD Diagnostic Products Business into the US Market
LabGenomics USA, a subsidiary of LabGenomics Co., Ltd., announced its acquisition of QDx Pathology, a leader in molecular and diagnostic pathology. The acquisition is expected to have significant impl
September 01, 11:00
Biocytogen Establishes Two Business Divisions To Distinguish Preclinical Models and Services (BioMice) from Antibody Drug R&D
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces the official formation of two major business divisions to represent the company’s product, service, and asset
August 30, 13:45
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, confirmed today that it is aware of an unsolicited partial tender offer from
August 29, 09:45
Sinovac Announces Change of Legal Representative of Sinovac Beijing
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the Company’s subsidiary, Sinovac Biotech Co., Ltd. (“S
August 28, 13:45
SUSMED’s DTx Approved in Japan for the Treatment of Insomnia
SUSMED, Inc. (TOKYO:4263) announced that it obtained regulatory approval from the Ministry of Health, Labour and Welfare (the “MHLW”) of SUSMED Med CBT-i® App for Insomnia (the “product”). SUSMED is i
August 25, 14:40
Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification
Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT® Solution, after receiving IVDR certification[*]. The EXENT solution is a fully integr
August 24, 15:45
Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
Royalty Pharma plc (Nasdaq: RPRX) and Ferring Pharmaceuticals today announced that Royalty Pharma has acquired a synthetic royalty on US net sales of Ferring’s Adstiladrin® (nadofaragene firadenovec-v
August 24, 09:15
Kenvue Becomes a Fully Independent Company Following Final Separation from Johnson & Johnson
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced its separation from Johnson & Johnson, marking its first day as a fully independent company. “This is a historic moment for Kenvue and with a sin
«
3
4
5
6
7
»
25 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
74,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 162 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Agriculture
Automobiles
Business
Construction / Realestate
Culture / Entertainment
Education
Energy / Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy / Government
Retail
Society
Sports
Technology
Transportation
Travel
Notice